Insulin resistance is the quietest metabolic problem there is. There is no pain, no obvious symptom, and no line on a standard blood report that names it. By the time it shows up as a raised fasting glucose, it has usually been building for a decade.
What insulin actually does
After a meal, carbohydrate is broken down into glucose and enters the bloodstream. The pancreas releases insulin, and insulin acts as a key — unlocking muscle, liver and fat cells so glucose can move out of the blood and be used or stored.
That system is elegant when it works. Glucose rises, insulin rises, glucose falls, insulin falls.
Where it breaks
Insulin resistance is what happens when the cells stop responding well to that key. The lock has not disappeared, but it has grown stiff. The pancreas responds the only way it can: it makes more insulin.
For years, this compensation works. Blood glucose stays normal on every test you take, because the pancreas is quietly working two or three times harder to keep it there. This is the critical window — and it is the one conventional screening misses entirely, because it measures glucose rather than the insulin required to hold that glucose down.
Eventually the pancreas cannot sustain the output. Glucose starts to drift up. Only then does the report change, and only then does most care begin.
What drives it
Several things push cells toward resistance, and they compound:
- Visceral fat. Fat stored around the organs is metabolically active tissue, releasing free fatty acids and inflammatory signals that directly interfere with insulin signalling.
- Chronic glucose load. Repeated large glucose excursions mean repeated large insulin releases. Persistently high insulin itself promotes further resistance.
- Poor sleep. A single week of restricted sleep measurably reduces insulin sensitivity in healthy adults.
- Chronic stress. Sustained cortisol raises blood glucose and drives visceral fat storage.
- Inactivity. Muscle is the largest glucose sink in the body. Unused muscle takes up far less glucose, regardless of diet.
- Genetics and ethnicity. South Asians develop insulin resistance at lower BMIs and lower body fat percentages than European populations — which is why Indian BMI cutoffs are set lower.
Why it matters beyond diabetes
Insulin resistance is not only a diabetes problem. It sits upstream of a long list of conditions that are usually treated as separate specialties: PCOS, fatty liver disease, hypertension, dyslipidaemia, and a meaningful share of cardiovascular risk.
Treat the resistance, and several downstream problems improve at once. Treat each downstream problem alone, and the cause keeps generating new ones.
How we find it early
Fasting glucose alone is a late signal. A fuller picture uses:
- Fasting insulin alongside fasting glucose, which allows a HOMA-IR calculation — an estimate of insulin resistance rather than glucose failure.
- HbA1c, giving a three-month average, though it can be misleading in anaemia and haemoglobin variants.
- Body composition, specifically visceral fat and skeletal muscle mass. Two people at the same weight can be metabolically opposite.
- Continuous glucose monitoring, which shows the size and duration of the excursions a fasting test never sees.
What reverses it
The encouraging part: insulin resistance is one of the most reversible conditions in metabolic medicine. The interventions that work are not exotic.
Build and use muscle. Resistance training two or three times a week increases the tissue that clears glucose, and a ten-minute walk after meals measurably blunts the post-meal rise.
Reduce the glucose load, not just the calories. Meal composition and sequence matter. Protein and fibre before refined carbohydrate flattens the curve considerably.
Prioritise sleep. Seven to nine hours is a metabolic intervention, not a lifestyle preference.
Lose visceral fat specifically. Even a 5–7% reduction in body weight, when it comes off the visceral compartment, produces disproportionate improvement in insulin sensitivity.
Use medication where it is indicated. Metformin and GLP-1 based therapies have a genuine role. They work best alongside the above, not instead of it.
The point
Insulin resistance is not a diagnosis you wait for. It is a process you can measure, interrupt and reverse — and the earlier you look, the less there is to undo.
If you have a family history of diabetes, unexplained fatigue, or weight that will not shift despite genuine effort, a metabolic assessment is worth doing well before a routine test flags anything.